Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders.
OBJECTIVE
Etiologically unexplained disorders of language and social development have often been reported to improve in patients treated with immune-modulating regimens. Here we determined the frequency of autoantibodies to brain among such children.


METHODS
We collected sera from a cohort of children with (1) pure Landau-Kleffner syndrome (n = 2), (2) Landau-Kleffner syndrome variant (LKSV, n = 11), and (3) autistic spectrum disorder (ASD, n = 11). None had received immune-modulating treatment before the serum sample was obtained. Control sera (n = 71) were from 29 healthy children, 22 with non-neurologic illnesses (NNIs), and 20 children with other neurologic disorders (ONDs). We identified brain autoantibodies by immunostaining of human temporal cortex and antinuclear autoantibodies using commercially available kits.


RESULTS
IgG anti-brain autoantibodies were present in 45% of sera from children with LKSV, 27% with ASD, and 10% with ONDs compared with 2% from healthy children and control children with NNIs. IgM autoantibodies were present in 36% of sera from children with ASD, 9% with LKSV, and 15% with ONDs compared with 0% of control sera. Labeling studies identified one antigenic target to be endothelial cells. Antinuclear antibodies with titers >/=1:80 were more common in children with ASD and control children with ONDs.


CONCLUSIONS
Children with LKSV and ASD have a greater frequency of serum antibodies to brain endothelial cells and to nuclei than children with NNIs or healthy children. The presence of these antibodies raises the possibility that autoimmunity plays a role in the pathogenesis of language and social developmental abnormalities in a subset of children with these disorders.
Connolly
A M
AM
Departments of Neurology and Pediatrics, Washington University, St. Louis Children's Hospital, St Louis, Missouri, USA.
Chez
M G
MG
Pestronk
A
A
Arnold
S T
ST
Mehta
S
S
Deuel
R K
RK
D000974:Antibodies, Antinuclear / Q000097:blood; D001321:Autistic Disorder / Q000276:immunology*; D001323:Autoantibodies / Q000032:analysis / Q000097:blood*; D001921:Brain / Q000276:immunology*; D002540:Cerebral Cortex / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007150:Immunohistochemistry; D007223:Infant; D018887:Landau-Kleffner Syndrome / Q000276:immunology*; D008297:Male; D009422:Nervous System Diseases / Q000276:immunology*; D013702:Temporal Lobe / Q000276:immunology
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M